Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Baranda JC"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Baranda JC; Department of Internal Medicine, University of Kansas Cancer Center, Fairway, Kansas, USA., Robbrecht D; Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Sullivan R; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts, USA., Doger B; START Madrid Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Santoro A; Department of Biomedical Sciences, Humanitas University Via Rita Levi Montalcini, Pieve Emanuele, Milan, Italy.; IRCCS Humanitas Research Hospital-Humanitas Cancer Center Via Manzoni, Rozzano, Milan, Italy., Barve M; Mary Crowley Cancer Research, Dallas, Texas, USA., Grob JJ; Aix Marseille University, Hôpital de la Timone, Marseille, France., Bechter O; Department of General Medical Oncology Leuven Cancer Institute, University Hospitals Leuven, KU Leuven, Leuven, Belgium., Vieito M; Vall d'Hebron University Hospital and Institute of Oncology (VHIO) Spain, Barcelona, Spain., de Miguel MJ; START-CIOCC HM Sanchinarro, Madrid, Spain., Schadendorf D; University of Essen and the German Cancer Consortium, Essen, Germany., Johnson M; Sarah Cannon Research Institute/Tennessee Oncology, PLCC, Nashville, Tennessee, USA., Pouzin C; Sanofi, Chilly-Mazarin, France., Cantalloube C; Sanofi, Chilly-Mazarin, France., Wang R; Sanofi, Cambridge, Massachusetts, USA., Lee J; Sanofi, Bridgewater, New Jersey, USA., Chen X; Sanofi, Bridgewater, New Jersey, USA., Demers B; Sanofi, Vitry-sur-Seine, France., Amrate A; Sanofi, Vitry-sur-Seine, France., Abbadessa G; Sanofi, Bridgewater, New Jersey, USA., Hodi FS; Department of Medical Oncology, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2024 Jun; Vol. 17 (6), pp. e13854.
Autor:
Acuña-Villaorduña A; Cancer Immunotherapy Program, Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY., Baranda JC; Early Phase Research, Clinical Research Center, University of Kansas Cancer Center, Fairway, KS., Boehmer J; Oncology Center of Excellence (OCE), US Food and Drug Administration, Silver Spring, MD., Fashoyin-Aje L; Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD., Gore SD; Early Therapeutics Clinical Trial Network, Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Shady Grove, MD.
Publikováno v:
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting [Am Soc Clin Oncol Educ Book] 2023 May; Vol. 43, pp. e389838.
Autor:
Baranda JC; Department of Medical Oncology, University of Kansas Cancer Center, Kansas City, KS, USA., Diaz FJ; Department of Biostatistics & Data Science, The University of Kansas Medical Center, Kansas City, KS, USA., Rubinstein L; National Cancer Institute, Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, Investigational Drug Branch, Bethesda, MD, USA., Shields AF; Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA., Dayyani F; Division of Hematology/Oncology, Department of Internal Medicine, Chao Family Comprehensive Cancer Center-University of California Irvine, Irvine, CA, USA., Mehta A; Division of Hematology and Oncology, Department of Internal Medicine, O'Neal Comprehensive Cancer Center-University of Alabama at Birmingham, Birmingham, AL, USA., Mehnert JM; Department of Internal Medicine, Perlmutter Cancer Center of NYU Langone, NYU Grossman School of Medicine, New York, NY, USA., Trent J; Department of Internal Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL, USA., Mabaera R; Section of Medical Oncology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA., Mooney M; National Cancer Institute, Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, Investigational Drug Branch, Bethesda, MD, USA., Moscow JA; National Cancer Institute, Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, Investigational Drug Branch, Bethesda, MD, USA., Doroshow J; National Cancer Institute, Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, Investigational Drug Branch, Bethesda, MD, USA., Waters B; National Cancer Institute, Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, Investigational Drug Branch, Bethesda, MD, USA., Ivy P; National Cancer Institute, Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, Investigational Drug Branch, Bethesda, MD, USA., Gore SD; National Cancer Institute, Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, Investigational Drug Branch, Bethesda, MD, USA., Thomas A; Department of Internal Medicine, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA.
Publikováno v:
JNCI cancer spectrum [JNCI Cancer Spectr] 2023 Jan 03; Vol. 7 (1).
Autor:
Hentzen S; Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA., Mehta K; Department of Oncology, University of Kansas Cancer Center, Kansas City, KS 66160, USA., Al-Rajabi RMT; Department of Oncology, University of Kansas Cancer Center, Kansas City, KS 66160, USA., Saeed A; Department of Oncology, University of Kansas Cancer Center, Kansas City, KS 66160, USA., Baranda JC; Department of Oncology, University of Kansas Cancer Center, Kansas City, KS 66160, USA., Williamson SK; Department of Oncology, University of Kansas Cancer Center, Kansas City, KS 66160, USA., Sun W; Department of Oncology, University of Kansas Cancer Center, Kansas City, KS 66160, USA., Kasi A; Department of Oncology, University of Kansas Cancer Center, Kansas City, KS 66160, USA.
Publikováno v:
Exploration of targeted anti-tumor therapy [Explor Target Antitumor Ther] 2023; Vol. 4 (3), pp. 396-405. Date of Electronic Publication: 2023 Jun 29.
Autor:
Coleman RL; US Oncology Research, The Woodlands, Texas, USA., Beck JT; Highlands Oncology Group, Fayetteville, Arkansas, USA., Baranda JC; University of Kansas Medical Center, Kansas City, Kansas, USA., Jacobs I; Pfizer Inc., New York, New York, USA., Smoyer KE; Envision Pharma Group, Philadelphia, Pennsylvania, USA., Lee LJ; Pfizer Inc., New York, New York, USA., Askerova Z; Pfizer Inc., New York, New York, USA., McGinnis J; Pfizer Inc., La Jolla, California, USA., Ganti AK; VA Nebraska Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, Nebraska, USA.
Publikováno v:
Oncology [Oncology] 2021; Vol. 99 (7), pp. 444-453. Date of Electronic Publication: 2021 Apr 06.
Autor:
O'Neil BH, Scott AJ, Ma WW, Cohen SJ, Aisner DL, Menter AR, Tejani MA, Cho JK, Granfortuna J, Coveler AL, Olowokure OO, Baranda JC, Cusnir M, Phillip P, Boles J, Nazemzadeh R, Rarick M, Cohen DJ, Radford J, Fehrenbacher L, Bajaj R, Bathini V, Fanta P, Berlin J, McRee AJ, Maguire R, Wilhelm F, Maniar M, Jimeno A, Gomes CL, Messersmith WA
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2016 Jun; Vol. 27 (6), pp. 1180. Date of Electronic Publication: 2016 Mar 03.
Autor:
O'Neil BH; Simon Cancer Center, Indiana University School of Medicine, Indianapolis., Scott AJ; University of Colorado, Denver, Aurora., Ma WW; Roswell Park Cancer Institute, Buffalo., Cohen SJ; Fox Chase Cancer Center, Philadelphia., Leichman L; New York University, New York., Aisner DL; University of Colorado, Denver, Aurora., Menter AR; Kaiser Permanente, Lone Tree., Tejani MA; University of Rochester Medical Center, Rochester., Cho JK; Oncare Hawaii, Honolulu., Granfortuna J; Cone Health Cancer Center, Greensboro., Coveler L; University of Washington, Seattle., Olowokure OO; University of Cincinnati Cancer Institute, Cincinnati., Baranda JC; University of Kansas Medical Center, Westwood., Cusnir M; Mount Sinai Medical Center, Miami Beach., Phillip P; Karmanos Cancer Institute, Detroit., Boles J; Rex Cancer Center UNC Healthcare, Raleigh., Nazemzadeh R; Carolinas Health Care, Charlotte., Rarick M; Kaiser Permanante Northwest, Portland., Cohen DJ; NYU Clinical Cancer Center, New York., Radford J; Hendersonville Hematology and Oncology at Pardee, Hendersonville., Fehrenbacher L; Kaiser Permanante Medical Center, Vallejo., Bajaj R; McLeod Regional Medical Center, Florence., Bathini V; University of Massachusetts Memorial, Worcester., Fanta P; UCSD Moores Cancer Center, La Jolla., Berlin J; Vanderbilt-Ingram Cancer Center, Nashville., McRee AJ; UNC Lineberger Comprehensive Cancer Center, Chapel Hill., Maguire R; Onconova Therapeutics Inc., Newtown., Wilhelm F; Onconova Therapeutics Inc., Newtown., Maniar M; Onconova Therapeutics Inc., Newtown., Jimeno A; University of Colorado, Denver, Aurora., Gomes CL; Oncology Consortia of Criterium Inc., Saratoga Springs, USA., Messersmith WA; University of Colorado, Denver, Aurora.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2015 Dec; Vol. 26 (12), pp. 2505. Date of Electronic Publication: 2015 Oct 21.
Autor:
Ramanathan RK; Arizona Cancer Center, University of Arizona, Tucson, Arizona.; Virginia G. Piper Cancer Center, Scottsdale Healthcare, Scottsdale, Arizona., McDonough SL; Southwest Oncology Group Statistical Center, Seattle, Washington., Kennecke HF; British Columbia Cancer Agency, Vancouver Centre, Vancouver, Canada., Iqbal S; USC Norris Comprehensive Cancer Center, Los Angeles, California., Baranda JC; University of Kansas Cancer Center, Westwood, Kansas., Seery TE; Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, California., Lim HJ; British Columbia Cancer Agency, Vancouver Centre, Vancouver, Canada., Hezel AF; James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York., Vaccaro GM; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Blanke CD; British Columbia Cancer Agency, Vancouver Centre, Vancouver, Canada.; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
Publikováno v:
Cancer [Cancer] 2015 Jul 01; Vol. 121 (13), pp. 2193-7. Date of Electronic Publication: 2015 Mar 30.
Autor:
Gordon MA; Department of Pathology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles., Gundacker HM; SWOG Statistical Center, Seattle., Benedetti J; SWOG Statistical Center, Seattle., Macdonald JS; Aptium Oncology, Inc., Los Angeles., Baranda JC; University of Kansas Cancer Center, Westwood., Levin WJ; Pfizer, Inc., San Diego., Blanke CD; Department of Medicine, Knight Cancer Institute, Oregon Health and Science University, Portland., Elatre W; Department of Pathology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles., Weng P; Department of Pathology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles., Zhou JY; Department of Pathology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles., Lenz HJ; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, USA., Press MF; Department of Pathology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles. Electronic address: press@usc.edu.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2013 Jul; Vol. 24 (7), pp. 1754-1761. Date of Electronic Publication: 2013 Mar 22.